Cargando…

Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study

Current treatment guidelines recommend anticoagulation for hypertrophic cardiomyopathy (HCM) with atrial fibrillation (AF) regardless of the CHA(2)DS(2)-VASc score. As aging and stroke risk factors (hypertension, diabetes mellitus) are confounders of ischemic stroke, young patients with a low stroke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Jung-Chi, Huang, Ya-Ting, Lin, Lian-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762520/ https://www.ncbi.nlm.nih.gov/pubmed/33226371 http://dx.doi.org/10.18632/aging.104133

Ejemplares similares

Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation – a nationwide cohort study
por: Lin, Ting-Tse, et al.
Publicado: (2019)

Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study
por: Liao, Min-Tsun, et al.
Publicado: (2021)

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
por: Choi, You-Jung, et al.
Publicado: (2022)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy
por: Komatsu, Junya, et al.
Publicado: (2021)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Left Atrial Appendage Closure for Primary and Secondary Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Pilot Study
por: Mo, Bin-Feng, et al.
Publicado: (2021)

Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke
por: Palà, Elena, et al.
Publicado: (2022)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
por: Khawaja, Tasveer, et al.
Publicado: (2023)

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy
por: She, Helen Hoi Lam, et al.
Publicado: (2015)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2022)

Atrial Function Assessment in High-Risk Hypertrophic Cardiomyopathy
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2023)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
por: Ikenaga, Hiroki, et al.
Publicado: (2017)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Liu, Li-Min, et al.
Publicado: (2020)

Association of Types of Sleep Apnea and Nocturnal Hypoxemia with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Xu, Haobo, et al.
Publicado: (2023)

Prognostic effect of atrial fibrillation on survival in patients with hypertrophic cardiomyopathy: a meta-analysis
por: Du, Meiling, et al.
Publicado: (2023)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Managing Stroke Prevention in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients Without Confirmed Persistent Atrial Fibrillation: A Dilemma of Anticoagulation
por: Henen, Christine, et al.
Publicado: (2023)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

Impact of Body Mass Index on Postoperative Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy
por: Zhang, Jian, et al.
Publicado: (2022)

Impact of Cryoballoon Ablation in Hypertrophic Cardiomyopathy-related Heart Failure due to Paroxysmal Atrial Fibrillation. A Comparative Case Series
por: Maagh, Petra, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation
por: Rochelson, Ellis, et al.
Publicado: (2018)

Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study
por: Berntsson, John, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ges7hfspict0ol3l8dji79pv1